However, loss of function mutations in KMT2C, a histone lysine methyltransferase, have been identified in a number of cancers,[36] and colorectal cancer cell lines,[37] pointing towards a tumour suppressor role. This evidence concerns the gene KMT2C and colorectal cancer.